131 related articles for article (PubMed ID: 7654429)
21. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
22. Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview.
Kaye SB; Piccart M; Aapro M; Francis P; Kavanagh J
Eur J Cancer; 1997 Nov; 33(13):2167-70. PubMed ID: 9470802
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
Clark TB; Kemeny NE; Conti JA; Huang Y; Andre AM; Stockman J
Cancer Invest; 1998; 16(5):314-8. PubMed ID: 9627678
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
Cascinu S; Graziano F; Barni S; Labianca R; Comella G; Casaretti R; Frontini L; Catalano V; Baldelli AM; Catalano G
Br J Cancer; 2001 Feb; 84(4):470-4. PubMed ID: 11207039
[TBL] [Abstract][Full Text] [Related]
25. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
Hudis CA; Seidman AD; Crown JP; Balmaceda C; Freilich R; Gilewski TA; Hakes TB; Currie V; Lebwohl DE; Baselga J; Raptis G; Gollub M; Robles M; Bruno R; Norton L
J Clin Oncol; 1996 Jan; 14(1):58-65. PubMed ID: 8558221
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
Rougier P
Anticancer Drugs; 1995 Jul; 6 Suppl 4():25-9. PubMed ID: 8745351
[TBL] [Abstract][Full Text] [Related]
27. A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
Perng RP; Shih JF; Chen YM; Chou KC; Lee YC; Tsai CM
Jpn J Clin Oncol; 2000 Oct; 30(10):429-34. PubMed ID: 11185888
[TBL] [Abstract][Full Text] [Related]
28. Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity.
Adjei AA; Klein CE; Kastrissios H; Goldberg RM; Alberts SR; Pitot HC; Sloan JA; Reid JM; Hanson LJ; Atherton P; Rubin J; Erlichman C
J Clin Oncol; 2000 Mar; 18(5):1116-23. PubMed ID: 10694565
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer.
Piccart MJ; Gore M; Ten Bokkel Huinink W; Van Oosterom A; Verweij J; Wanders J; Franklin H; Bayssas M; Kaye S
J Natl Cancer Inst; 1995 May; 87(9):676-81. PubMed ID: 7752272
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of docetaxel in non-small cell lung cancer patients previously treated with platinum-containing chemotherapy. French Group of Pneumo-Cancerology].
Robinet G; Thomas P; Pérol M; Vergnenègre A; Lena H; Taytard A; Paillotin D; Bessa EH; Schuller-Lebeau MP
Rev Mal Respir; 2000 Feb; 17(1):83-9. PubMed ID: 10756559
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients.
de Wit R; Kruit WH; Stoter G; de Boer M; Kerger J; Verweij J
Br J Cancer; 1998 Nov; 78(10):1342-5. PubMed ID: 9823976
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Norris CM; Rossi RM; Lucarini JW; Busse PM; Poulin MD; Thornhill L; Costello R; Posner MR
J Clin Oncol; 1996 May; 14(5):1672-8. PubMed ID: 8622087
[TBL] [Abstract][Full Text] [Related]
33. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
[TBL] [Abstract][Full Text] [Related]
34. Early clinical studies with docetaxel. Docetaxel Investigators Group.
Aapro M; Bruno R
Eur J Cancer; 1995; 31A Suppl 4():S7-10. PubMed ID: 7577102
[TBL] [Abstract][Full Text] [Related]
35. Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancer.
Ravdin PM; Valero V
Semin Oncol; 1995 Apr; 22(2 Suppl 4):17-21. PubMed ID: 7740326
[TBL] [Abstract][Full Text] [Related]
36. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.
Piccart MJ; Klijn J; Paridaens R; Nooij M; Mauriac L; Coleman R; Bontenbal M; Awada A; Selleslags J; Van Vreckem A; Van Glabbeke M
J Clin Oncol; 1997 Sep; 15(9):3149-55. PubMed ID: 9294478
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel.
Cortes JE; Pazdur R
J Clin Oncol; 1995 Oct; 13(10):2643-55. PubMed ID: 7595719
[TBL] [Abstract][Full Text] [Related]
39. [Phase II study of docetaxel in inoperable advanced non small cell lung cancer].
Robinet G; Thomas P; Pérol M; Vergnenegre A; Lena H; Taytard A; Paillotin D; Bessa EH; Schuller-Lebeau MP
Bull Cancer; 2000 Mar; 87(3):253-8. PubMed ID: 10779813
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
Hesketh PJ; Crowley JJ; Burris HA; Williamson SK; Balcerzak SP; Peereboom D; Goodwin JW; Gross HM; Moore DF; Livingston RB; Gandara DR
Cancer J Sci Am; 1999; 5(4):237-41. PubMed ID: 10439170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]